Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free
Über uns | Dr. Andreas Rieker | Praxis Neckarwestheim
Open‐label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients - Rieker‐ Schwienbacher - 2013 - Clinical and Translational Allergy - Wiley Online Library